H. Michael Petrassi, PhD
H. Michael Petrassi brings more than 20 years of medicinal chemistry and drug discovery experience to Protego. Michael was most recently San Diego Site Head and Vice President of Medicinal Chemistry at Treeline Biosciences. Prior to Treeline he was Vice President of Medicinal Chemistry at Calibr at Scripps Research. He led discovery chemistry research teams across multiple disease areas in order to translate innovative Scripps Research discoveries into clinical-stage compounds. Dr. Petrassi began his career in drug discovery at the Genomics Institute of the Novartis Research Foundation, where he led the medicinal chemistry efforts on several projects, most notably in regenerative medicine, which delivered clinical-stage assets into the Novartis pipeline. He earned his PhD in organic chemistry from the Scripps Research Institute, and a BS in chemistry from the State University of New York at Fredonia.